Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus IpilimumabByYuly A. Remolina-Bonilla, MD,Brenda Jimenez-Franco, MD,María T. Bourlon, MD, MSc, FASCO,Elaine T. Lam, MDMay 13th 2020Experts discuss the case of a 56-year-old white man who presents with multiple immune-related adverse events